Qiu Doctor Chief Physician

Peking University Third Hospital · Urology · Chief Physician

An Associate Chief Physician specializing in urological tumors, renal diseases, calculi, and benign prostatic hyperplasia. Expert in NBI-assisted bladder tumor resection and robot-assisted laparoscopic surgeries, including radical nephrectomy and nephron-sparing procedures. Experienced in treating rare renal cell carcinoma subtypes and complex stones. Holds multiple patents, published over 50 articles, and received several awards for medical innovation and excellence.

Renal cell carcinoma, renal pelvic and ureteral tumors, calculi, minimally invasive surgery.

Qiu Doctor
Basic Information

About Dr. Qiu Doctor

Hospital
Peking University Third Hospital
Title
Chief Physician
Department
Urology
Years of Practice
28 years (1998 — present)
Professional Title: Associate Chief Physician Specialties: Specializes in the diagnosis and treatment of urological tumors (particularly renal tumors), calculi, and benign prostatic hyperplasia. Has long adhered to NBI-assisted transurethral resection of bladder tumors, significantly reducing the recurrence rate of bladder cancer and achieving optimal therapeutic outcomes for patients. Currently primarily dedicated to research on kidney diseases, with extensive experience in renal cell carcinoma (especially rare and special pathological subtypes), urothelial carcinoma, and renal calculi. Proficient in robot-assisted laparoscopic radical nephrectomy, nephron-sparing surgery (including partial nephrectomy and endoscopic nephron-sparing tumor resection), laparoscopic nephroureterectomy, flexible ureteroscopic lithotripsy, and percutaneous nephrolithotomy. Additionally skilled in performing complex procedures such as transurethral holmium laser enucleation of the prostate and robot-assisted laparoscopic radical prostatectomy. Work Experience 2003-2011: Peking University (Eight-year Clinical Medicine Program, combined Bachelor's and Doctoral degrees), awarded Doctor of Medicine April 2009 - July 2014: Peking University Third Hospital, Resident Physician August 2014 - July 2019: Peking University Third Hospital, Attending Physician August 2019 - Present: Peking University Third Hospital, Associate Chief Physician Research Activities Currently leads and participates in multiple research grants, undertakes a new technology project for renal tumors at Peking University Third Hospital, and has obtained multiple patents. Awards 2014: Outstanding Resident Physician, Peking University 2017: Excellent Paper Award, Chinese Journal of Urology 2023: Medical Technology Innovation Award, Peking University Third Hospital Publications Has published over 50 articles, with representative publications on renal tumors as follows: 1. Difficulties and strategies in laparoscopic surgery for renal tumors. Journal of Clinical Urology, 2014, 29(6): 463-467. 2. Multiple primary tumors including renal schwannoma: a case report and literature review. Journal of Peking University (Health Sciences), 2015, 47(4): 714-717. 3. Diagnosis and treatment of multiple primary cancers complicated with renal cell carcinoma. Journal of Peking University (Health Sciences), 2016, 48(5): 926-inside back cover. 4. Experience in diagnosis and treatment of clear cell papillary renal cell carcinoma. Chinese Journal of Urology, 2016, 37(9): 655-659. 5. Efficacy analysis of retroperitoneal laparoscopic partial nephrectomy under real-time ultrasound monitoring for completely endophytic renal tumors. Chinese Journal of Urology, 2016, 37(10): 730-734. 6. Technical considerations for retroperitoneal laparoscopic partial nephrectomy in the treatment of giant (>8cm) renal angiomyolipomas. Chinese Journal of Minimally Invasive Surgery, 2017, 17(10): 905-908. 7. Experience in diagnosis and treatment of sporadic multiple malignant renal tumors. Chinese Journal of Urology, 2018, 39(9): 672-675. 8. One-stage minimally invasive surgery for renal masses complicated with ureteral calculi. Chinese Journal of Minimally Invasive Surgery, 2018, 18(11): 1027-1029. 9. Minimally invasive surgery for renal cell carcinoma with Mayo grade 0-2 venous tumor thrombus: a single-center study. Journal of Peking University (Health Sciences), 2018, 50(6): 1053-1056. 10. Simultaneous retroperitoneal laparoscopic and endoscopic treatment of renal masses complicated with bladder masses. Chinese Journal of Minimally Invasive Surgery, 2019, 19(8): 692-695. 11. A retrospective study on the diagnosis and treatment of renal oncocytoma. Journal of Peking University (Health Sciences), 2019, 51(4): 689-693. 12. Experience in diagnosis and treatment of metanephric adenoma and literature review. Journal of Peking University (Health Sciences), 2021, 53(2): 417-419. 13. Application of perirenal fascia suspension device in retroperitoneal laparoscopic partial nephrectomy. Journal of Peking University (Health Sciences), 2021, 53(4): 789-792. 14. Feasibility of laparoscopic partial nephrectomy for renal tumors with R.E.N.A.L. score of 10. Chinese Journal of Urology, 2022, 43(5): 339-343. 15. Treatment and prognosis of multiple primary cancers complicated with renal cell carcinoma. Journal of Peking University (Health Sciences), 2022, 54(4): 680-685. 16. Clinicopathological characteristics and prognostic analysis of renal tumors with tumor thrombus in young patients. Journal of Peking University (Health Sciences), 2023, 55(5): 802-811. 17. Efficacy of laparoscopic partial nephrectomy for renal tumors of moderate-to-high complexity. Journal of Peking University (Health Sciences), 2023, 55(5): 833-837. 18. Experience in diagnosis, treatment, and prognosis of fumarate hydratase-deficient renal cell carcinoma with tumor thrombus. Chinese Journal of Urology, 2023, 44(6): 416-421. 19. Clinical characteristics and mid-to-long-term postoperative follow-up of 23 cases of clear cell papillary renal cell tumor. Chinese Journal of Minimally Invasive Surgery, 2024, 24(11): 721-725. 20. Diagnosis and treatment of 6 cases of renal Ewing sarcoma with venous tumor thrombus. Journal of Peking University (Health Sciences), 2024, 56(4): 636-639. 21. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors. World J Urol, 2024, 31;42(1): 364-374. 22. Clinicopathological characteristics and prognosis of non-clear cell renal malignant tumors in young patients (aged 18-40). Journal of Modern Urology, 2024, 29(1): 60-64. Books and Translations Chief Editor of *Handbook of Endourology: From Surgical Treatment to Nursing Practice* and *Kidney Surgical Diseases: A Patient Consultation Guide*; Associate Editor of *Diagnosis and Treatment of Urological Tumors with Venous Tumor Thrombus* and *Experts Teach You to Understand Medical Imaging Results*. Contributing author or translator of *Analysis of Challenging Cases in Urology*, *Smith's Textbook of Endourology* (2nd Edition, authored by Smith, USA), *Minimally Invasive Urological Surgery* (2nd Edition), and *Challenging Issues in Laparoscopic Urological Surgery*, among others.
Schedule

Dr. Qiu Doctor — Outpatient Schedule

Weekly clinic, including specialist and surgery days. Book 3-7 days in advance.

Clinic: Peking University Third Hospital · Urology
On Duty
Off Duty
Period Morning
08:00-12:00
Afternoon
14:00-17:30
Evening
18:30-20:30
Mon Off Duty Off Duty Off Duty
Tue
08:00 - 12:00
Off Duty Off Duty
Wed Off Duty
13:00 - 17:00
Off Duty
Thu Off Duty Off Duty Off Duty
Fri Off Duty Off Duty Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: Actual clinic hours are subject to the hospital's daily notice. Please call the Dovecure 24h hotline 400-888-0000 to confirm before booking.

Rationale for Precision

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Book your dedicated advisor now

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Consult Now
24/7 medical consultation +86 18126771334 (iMessage)
Email Consultation cure@dovecure.com
WhatsApp WeChat QR Code WeChat QR Code
Cart
Your cart is empty
Continue shopping
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
Total {{ totalAmount }}
Checkout View Cart
Consult